Professor of Radiology

Email: pcaravan@partners.org

Further Information

---

Recent Publications

• Ning Y, Zhou IY, Schaub JR, Rotile NJ, Boice A, Ay I, Turner S, Caravan P. Multimodal Imaging Demonstrates Antifibrotic Effects of Targeting avß6/avß1 Integrins in Biliary Fibrosis. Invest Radiol. 2025 May 01.
• Allison MB, Catana C, Zhou IY, Caravan P, Montesi SB. Molecular Imaging of Pulmonary Fibrosis. J Nucl Med. 2025 Apr 01. 66(4):502-505
• Montesi SB, Cosgrove GP, Turner SM, Zhou IY, Efthimiou N, Susnjar A, Catana C, Fromson C, Clark A, Decaris M, Barnes CN, Lefebvre ÉA, Caravan P. Dual avß6 and avß1 Inhibition Over 12 Weeks Reduces Active Type 1 Collagen Deposition in Individuals with Idiopathic Pulmonary Fibrosis: A Phase 2, Double-Blind, Placebo-controlled Clinical Trial. Am J Respir Crit Care Med. 2025 Mar 28.
• Spreckelmeyer S, Dasilva J, Decristoforo C, Mach RH, Passchier J, Carlucci G, Qahtani MA, Duatti A, Cornelissen BT, Engle J, Denkova A, Hendrikx JJMA, Seimbille Y, Yang X, Jia H, Zhang MR, Yang M, Perk L, Caravan P, Laverman P, Cheng Z, Hoehr C, Sakr T, Zeevaart JR. Highlight selection of radiochemistry and radiopharmacy developments by editorial board. EJNMMI Radiopharm Chem. 2025 Mar 25. 10(1):13
• Quintana JM, Jiang F, Kang M, Valladolid Onecha V, Könik A, Qin L, Rodriguez VE, Hu H, Borges N, Khurana I, Banla LI, Le Fur M, Caravan P, Schuemann J, Bertolet A, Weissleder R, Miller MA, Ng TSC. Localized In Vivo Prodrug Activation Using Radionuclides. J Nucl Med. 2025 Jan 03. 66(1):91-97